Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 13 February 2026Expected publication date: 21 May 2026
Nerandomilast for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis ID6446Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 9 September 2026
Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal) (TA1111)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 19 November 2025